The increasing digitalization of health systems is accelerating the transition towards a new era of data-driven, evidence-based care. This has profound implications for clinical practice, performance evaluation, policy making and biomedical research. At the heart of this transformation lies a healthcare data warehouse (DW), which functions as a critical infrastructure for aggregating, standardizing, and analyzing […]
FAIR foundations of a novel indicator vault for non-communicable diseases in the European Union: feasibility study for effective contextualisation of indicators
BackgroundComparing health indicators across the European Union (EU) is a challenging endeavour. A feasibility study was conducted to explore opportunities for improvement through the contextualisation of indicators for major non-communicable diseases (NCDs). We aimed to improve the usability and transparency of indicators in the domain of NCDs by describing the contextual information about the data […]
Implementation and outcomes of a digital onboarding taskforce in the acute care setting
IntroductionUse of digital health technology can improve patient health outcomes; however, not all patients have the knowledge and skills to download a health app and access a patient portal. Providing digital onboarding support to hospitalized patients has potential to overcome some barriers to accessing needed education in the community, including both having the time and […]
Effectiveness of an integrated community and hospital digital health information system for maternal and newborn healthcare in Northern Kenya: a nonrandomized before-after evaluation
BackgroundPoor access to antenatal care (ANC), skilled delivery, and postnatal checks within 48 h of delivery are linked to adverse pregnancy outcomes. In Kenya, unequal use of these services has caused significant regional disparities, with 15 out of 47 counties being high priority.ObjectivesTo evaluate the effectiveness of a digital health solution to improve maternal and newborn […]
ScolioClass: data-driven development of a new classification tool to evaluate adolescent idiopathic scoliosis optically diagnosed
Adolescent idiopathic scoliosis (AIS) is traditionally assessed and classified using radiographic methods that rely on Cobb angle measurements and qualitative curve modifiers, exposing patients to repeated radiation and offering limited sensitivity to subtle three-dimensional (3D) deformities. We developed ScolioClass, a non-invasive, data-driven classification tool that harnesses 3D optical surface scanning and continuous indices, capturing curvature […]
One digital health through wearables: a viewpoint on human–pet integration towards Healthcare 5.0
Wearable technologies mark a transition in healthcare evolution, from paternalistic (Healthcare 1.0) to reactive (Healthcare 2.0), proactive (Healthcare 3.0), and data-integrated care (Healthcare 4.0). The next stage, Healthcare 5.0, envisions the seamless integration of human and pet health data, fostering a more holistic approach to disease prevention and management. In this viewpoint, we explore the […]
Impact of telehealth on health outcomes and quality of life in the older adults population: a systematic review
BackgroundThe rapid aging of populations poses major challenges to health and social care systems. Supporting older adults in managing chronic conditions while promoting independence and quality of life requires innovative approaches that extend beyond senior institutional care. Telehealth has emerged as a promising approach to enhance access, continuity, and patient engagement. However, evidence regarding its […]
Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Eli Lilly’s experimental obesity pill allowed patients who had lost weight on injected GLP-1-based drugs to keep most of the weight off for another year, according to data from a Phase 3 trial released Thursday …
Steve Paul’s post-Karuna act draws $165M to schizophrenia biotech Syremis
Steve Paul is back with a fresh take on schizophrenia drugs, co-founding a new biotech called Syremis Therapeutics that’s already landed $165 million in a Series A, Endpoints News has learned. The serial founder and …
MSD claims two national priority vouchers; report
The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD drug candidates.